BSECompany UpdateM&A18h ago
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, as amended ("SEBI (SAST) Regulations") cum Corrigendum to the Detailed Public Statement for the attention of the public shareholders of Kronox Lab Sciences Ltd ("Target Company").
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited for the acquisition of equity shares. The offer opening public announcement cum corrigendum has been published in various newspapers. The tendering period for the offer will commence on November 6, 2026.
BSEResultResults20h ago
Kronox Lab Sciences Ltd
Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026
Kronox Lab Sciences Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a profit after tax of Rs 1,374.33 lakhs and a comprehensive income of Rs 1,371.78 lakhs. The company has also reported a change in controlling stake with Indo Borax & Chemicals Limited becoming the holding company after acquiring 64.26% of the paid-up equity shares capital.
BSEBoard MeetingResults21h ago
Kronox Lab Sciences Ltd
Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026
Kronox Lab Sciences Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company's revenue from operations was Rs. 2,683.42 lakhs, with other income of Rs. 86.87 lakhs. The total income was Rs. 2,770.29 lakhs. Expenses included cost of materials consumed of Rs. 1,108.38 lakhs, employee benefit expenses of Rs. 190.60 lakhs, and finance costs of Rs. 7.85 lakhs. The company reported a profit after tax of Rs. 644.03 lakhs for the quarter and Rs. 730.30 lakhs for the half year. The earnings per equity share (EPS) was Rs. 173 for the quarter and Rs. 197 for the half year.
BSECompany UpdateM&A2d ago
Kronox Lab Sciences Ltd
Publication of recommendation of Independent Directors Committee held on November 02, 2026.
Kronox Lab Sciences Ltd has announced the publication of the recommendation of the Independent Directors Committee regarding the open offer for the acquisition of up to 95.70 lakh equity shares of the company by Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited.
BSEBoard MeetingResults6d ago
Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results for the Quarter and half year ended September 30, 2026
Kronox Lab Sciences Ltd has scheduled a Board Meeting on November 05, 2026, to consider and approve Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.
BSECompany UpdateFundraise29 Oct 2026
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, at ₹157.27 per share.
BSECompany UpdateM&A23 Oct 2026
Kronox Lab Sciences Ltd
Disclosure under Regulation 30A of SEBI (LODR) - Amendment of the Share Purchase Agreement
Kronox Lab Sciences Ltd has disclosed an amendment to the share purchase agreement between Indo Borax and Chemicals Limited, Zenrock Chemicals Private Limited, and the erstwhile promoters of the company, Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani, and Mr. Jogindersingh Gianchand Jaswal. The amendment deletes clauses related to lock-in and right of first refusal, allowing the sellers to freely trade their shares.
BSEGeneral▲ PositiveExpansion14 Oct 2026
Kronox Lab Sciences Ltd
Outcom of Board Meeting held on October 14, 2026 to discuss agenda for acquition of Plant at Dahej, SEZ
Kronox Lab Sciences Ltd has announced the acquisition of a plant in Dahej Special Economic Zone from Axiom Chemicals Private Limited to expand its manufacturing capacity for business growth.
BSECompany Update▲ PositiveExpansion14 Oct 2026
Kronox Lab Sciences Ltd
Acquition of a Plant adm. about 5000 Sq. Meters located in Dahej SEZ fromAxiom Chemicals Private Limited
Kronox Lab Sciences Ltd has acquired a plant measuring about 5000 Sq. meters located in a Dahej Special Economic Zone from Axiom Chemicals Private Limited. The acquisition is to expand manufacturing capacity for business growth.
BSECompany Update5 Oct 2026
Kronox Lab Sciences Ltd
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Kronox Lab Sciences Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, regarding the dematerialization and rematerialization of securities for the quarter ended September 30, 2026.
BSECompany UpdateRelated Party1 Oct 2026
Kronox Lab Sciences Ltd
Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015 - Informatioin and Update
Kronox Lab Sciences Ltd has made disclosures under Regulation 7(2) of SEBI (PIT) Regulations, 2015, regarding the sale of shares by promoters Mr. Jogindersingh Jaswal, Mr. Ketan Ramani, and Mr. Pritesh Ramani, representing approximately 23.09% and 18.09% of the company's total paid-up equity share capital.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences has informed BSE about an intimation on agreements, but no further details are provided.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.
BSECompany Update30 Sept 2026
KRONOX LAB SCIENCES LIMITED
KRONOX LAB SCIENCES LIMITED has informed BSE about Intimation on Agreements.
Kronox Lab Sciences Limited has informed BSE about an intimation on agreements.